Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden
· Delayed Price · Currency is SEK 5.33
-0.05 (-0.93%)
Jul 8, 2025, 1:28 PM CET
Elicera Therapeutics AB Revenue
Elicera Therapeutics AB had revenue of 218.86K SEK in the quarter ending March 31, 2025, a decrease of -92.79%. This brings the company's revenue in the last twelve months to 4.31M, down -66.45% year-over-year. In the year 2024, Elicera Therapeutics AB had annual revenue of 7.13M, down -36.52%.
Revenue (ttm)
4.31M
Revenue Growth
-66.45%
P/S Ratio
60.56
Revenue / Employee
2.16M
Employees
2
Market Cap
261.12M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.31B |
| Getinge AB | 35.57B |
| Asker Healthcare Group AB | 15.57B |
| Medicover AB | 23.56B |
| Camurus AB | 2.04B |
| AddLife AB | 10.42B |
| Vimian Group AB | 4.24B |